Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Metabolic Engineering
|
September 20, 2015
Introduction of a bacterial acetyl-CoA synthesis pathway improves lactic acid production in Saccharomyces cerevisiae
Ji-Yoon Song, Joon-Song Park, Chang Duk Kang, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2014
Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation
Yong Rae Hong, Hyun Tae Kim, Seonggu Ro, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 18, 2013
[(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues
Yong Rae Hong, Hyun Tae Kim, Seung-Chul Lee, et al.
Nature Biotechnology
|
March 8, 2011
Conversion of proteins into biofuels by engineering nitrogen flux
Yi-Xin Huo, Kwang Myung Cho, Jimmy G Lafontaine Rivera, et al.
Journal of Cancer
|
May 6, 2020
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Young-Dae Kim, Sang-Min Park, Hae Chan Ha, et al.
Journal of Structural Biology
|
November 25, 2010
Structural basis of triclosan resistance
N Jiten Singh, Dongkyu Shin, Han Myoung Lee, et al.
Cell Chemical Biology
|
February 13, 2018
Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase
Hyun Tae Kim, Byeong Kwan Na, Jiwoung Chung, et al.
Oncology Reports
|
February 13, 2015
Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL
Jong Kyu Woo, Ju-Hee Kang, Yeong-Su Jang, et al.
Antimicrobial Agents and Chemotherapy
|
April 11, 2007
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea
Jong Hwa Yum, Chang Ki Kim, Dongeun Yong, et al.
Biotechnology and Bioengineering
|
January 23, 2014
Engineering of a butyraldehyde dehydrogenase of Clostridium saccharoperbutylacetonicum to fit an engineered 1,4-butanediol pathway in Escherichia coli
Hee Jin Hwang, Jin Hwan Park, Jin Ho Kim, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Metabolic Engineering
|
September 20, 2015
Introduction of a bacterial acetyl-CoA synthesis pathway improves lactic acid production in Saccharomyces cerevisiae
Ji-Yoon Song, Joon-Song Park, Chang Duk Kang, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2014
Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation
Yong Rae Hong, Hyun Tae Kim, Seonggu Ro, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 18, 2013
[(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues
Yong Rae Hong, Hyun Tae Kim, Seung-Chul Lee, et al.
Nature Biotechnology
|
March 8, 2011
Conversion of proteins into biofuels by engineering nitrogen flux
Yi-Xin Huo, Kwang Myung Cho, Jimmy G Lafontaine Rivera, et al.
Journal of Cancer
|
May 6, 2020
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Young-Dae Kim, Sang-Min Park, Hae Chan Ha, et al.
Journal of Structural Biology
|
November 25, 2010
Structural basis of triclosan resistance
N Jiten Singh, Dongkyu Shin, Han Myoung Lee, et al.
Cell Chemical Biology
|
February 13, 2018
Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase
Hyun Tae Kim, Byeong Kwan Na, Jiwoung Chung, et al.
Oncology Reports
|
February 13, 2015
Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL
Jong Kyu Woo, Ju-Hee Kang, Yeong-Su Jang, et al.
Antimicrobial Agents and Chemotherapy
|
April 11, 2007
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea
Jong Hwa Yum, Chang Ki Kim, Dongeun Yong, et al.
Biotechnology and Bioengineering
|
January 23, 2014
Engineering of a butyraldehyde dehydrogenase of Clostridium saccharoperbutylacetonicum to fit an engineered 1,4-butanediol pathway in Escherichia coli
Hee Jin Hwang, Jin Hwan Park, Jin Ho Kim, et al.
Page
of 7